Drug General Information
Drug ID
D07FBM
Former ID
DNCL002834
Drug Name
ASP1941
Drug Type
Small molecular drug
Indication Liver disease [ICD9: 570-574; ICD10:K70-K77] Phase 3 [522923]
Company
Astellas Pharma US
Structure
Download
2D MOL

3D MOL

Formula
C26H30FNO7S
Canonical SMILES
C1CC(NC1)C(=O)O.C1=CC=C2C(=C1)C=C(S2)CC3=C(C=CC(=C3)C4C<br />(C(C(C(O4)CO)O)O)O)F
InChI
1S/C21H21FO5S.C5H9NO2/c22-15-6-5-12(21-20(26)19(25)18(24)16(10-23)27-21)7-13(15)9-14-8-11-3-1-2-4-17(11)28-14;7-5(8)4-2-1-3-6-4/h1-8,16,18-21,23-26H,9-10H2;4,6H,1-3H2,(H,7,8)/t16-,18-,19+,20-,21+;4-/m10/s1
InChIKey
TUVGWWULBZIUBS-FVYIYGEMSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) SLGT2 Target Info Modulator
Reactome Hexose transport
Na+-dependent glucose transporters
Inositol transporters
WikiPathways NRF2 pathway
Nuclear Receptors Meta-Pathway
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
References
Ref 522923ClinicalTrials.gov (NCT01054092) A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic Patients. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.